Europe Sustained Release Excipients Market

Europe Sustained Release Excipients Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Product (Polymers, Minerals, Sugars, Gelatin & Chitosan), By Technology, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-12128 Publication Date: October-2022 Number of Pages: 105
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Europe Sustained Release Excipients Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028).

Methacrylate polymers, which also offer gastro-resistant functionality, are frequently utilized in delayed-release dosage forms. Although the usage of two-polymer matrix systems is expanding, hydroxypropyl methylcellulose (HPMC) remains the excipient of choice in monolithic delivery systems. Matrix systems and functional coatings are the two main formulation techniques that can be used to create sustained release kinetics.

In order to produce a membrane surrounding the tablet that regulates the pace of API release in relation to the rate of coating layer evaporation through which the medicine will diffuse and dissolve, functional coatings are used. These reservoir systems are another name for such sustained release systems. This strategy can be flexible because the pores, coating type, and thickness can all be changed to alter the controlled release profile. The API is uniformly disseminated within a matrix made of polymers in formulations for sustained release based on a matrix.

Matrix systems are divided into hydrophobic and hydrophilic matrix systems based on the rate-controlling polymeric characteristics, which exhibit various release mechanisms. The API is released by diffusion through the thick gel layer and also by matrix erosion in the hydrophilic type of matrix systems. In this, the polymer hydrates and expands upon contact with the gastrointestinal medium, generating a gel layer on the system's surface. Different polymer kinds, grades, and quantities can be used to modify released kinetics, but they also depend on the solubility of the API.

Due to the aging populations, non-communicable diseases, multimorbidity, and frailty in Europe, the emergence of diseases like COVID-19 are especially pertinent. A study conducted throughout the region reported that the nations with the largest percentages of senior citizens were Finland, Italy, Greece, Portugal, and Germany. The report indicated that in these countries older people were living with disabilities on average. But the greatest rates were found in Bulgaria, Croatia, and Hungary. Additionally, the region's burden of cardiovascular diseases (CVD) goes beyond mortality. A high prevalence of the disease/disorder is observed in Eastern Europe than in the western part.

The Germany market dominated the Europe Sustained Release Excipients Market by Country in 2021; thereby, achieving a market value of $153.4 million by 2028. The UK market would showcase a CAGR of 7.2% during (2022 - 2028). Additionally, The France market is anticipated to grow at a CAGR of 8.9% during (2022 - 2028).

Based on Route of Administration, the market is segmented into Oral, Transdermal, Vaginal, Intravenous, Ophthalmic, Subcutaneous, Intramuscular, and Others. Based on Product, the market is segmented into Polymers, Minerals, Sugars, Gelatin & Chitosan, and Others. Based on Technology, the market is segmented into Targeted Delivery, Implants, Wurster Technique, Transdermal, Micro Encapsulation, and Coacervation & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Sustained Release Excipients Market will Hit $1.9 Billion by 2028, at a CAGR of 8.4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefossé, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.

Scope of the Study

Market Segments Covered in the Report:

By Route of Administration

  • Oral
  • Transdermal
  • Vaginal
  • Intravenous
  • Ophthalmic
  • Subcutaneous
  • Intramuscular
  • Others

By Product

  • Polymers
  • Minerals
  • Sugars
  • Gelatin & Chitosan
  • Others

By Technology

  • Targeted Delivery
  • Implants
  • Wurster Technique
  • Transdermal
  • Micro Encapsulation
  • Coacervation & Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • International Flavors & Fragrances, Inc.
  • Ashland Global Holdings Inc.
  • Evonik Industries AG
  • Croda International Plc
  • Gattefossé
  • Merck Group
  • Pfizer, Inc.
  • Novartis AG
  • AstraZeneca Plc
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo